申请人:Asahi Kasei Kogyo Kabushiki Kaisha
公开号:EP0090972A2
公开(公告)日:1983-10-12
A compound of the formula (I):
wherein
W, and W2 each independently is a hydrogen atom or a
group wherein Y is a n-C1-6 alkvlene group or a n-C1-6 alkylene group having a C1-6 alkyl group substituent; and R, and R2 each independently is a hydrogen atom or a C1-5 alkyl group, and
group in
group may form a saturated heterocyclic ring selected from the group consisting of morphohno. pyrrolidino, piperidino, homopiperidino and piperazino groups. and the saturated heterocyclic ring except the morpholino group may have at least one C1-4 alkyl group, hydroxyl group or halogen atom as a substituent;
Z, is a hydrogen atom, a chlorine atom, a bromine atom, an iodine atom, a hydroxyl group, an amino group, a C1-3 alkyl group or a methoxy group;
Z2 is a hydrogen atom or an amino group;
when W, and W2 are both hydrogen atoms, Z, is a hydroxyl group or an iodine atom and Z2 is hydrogen atom, or Z, and 22 are both amino groups;
When Z, and 22 are both hydrogen atoms, the
group in either W, or W2 is a morpholino group;
when Z, is a chlorine atom, a hydroxyl group, an iodine atom, a methyl group or a methoxy group, Z2 is a hydrogen atom;
when Z, is an amino group, Z2 is a hydrogen atom or an amino group;
when Z, is a methyl group, a methoxy group or an amino group, Z, is in the 5-position; when Z, is an iodine atom, Z, is in the 5- or 7-position; and when Z, and Z2 are both amino groups. Z, and Z2 are in the 5- and 7-positions; and the physiologically acceptable acid addition salt thereof.
式 (I) 的化合物:
其中
W和W2各自独立地为
氢原子或基团,其中
其中 Y 是 n-C1-6
烯基或具有 C1-6 烷基取代基的 n-C1-6
烯基;以及 R 和 R2 各自独立地是
氢原子或 C1-5 烷基,且
中的基团
除
吗啉基外,饱和杂环可具有至少一个 C1-4 烷基、羟基或卤原子作为取代基;
Z 是
氢原子、
氯原子、
溴原子、
碘原子、羟基、
氨基、C1-3 烷基或甲
氧基;
Z2 是
氢原子或
氨基;
当 W 和 W2 都是
氢原子时,Z 是羟基或
碘原子,Z2 是
氢原子,或 Z 和 22 都是
氨基;
当 Z 和 22 均为
氢原子时,则
当 Z 和 22 均为
氢原子时,W 或 W2 中的基团为
吗啉基;
当 Z 为
氯原子、羟基、
碘原子、
甲基或甲
氧基时,Z2 为
氢原子;
当 Z 为
氨基时,Z2 为
氢原子或
氨基;
当 Z 是
甲基、甲
氧基或
氨基时,Z 在 5 位;当 Z 是
碘原子时,Z 在 5 或 7 位;当 Z 和 Z2 都是
氨基时。Z和Z2分别位于5和7位;及其生理学上可接受的酸加成盐。